companydata.dkcompanydata.dk

Sunrise Medical ApS: Financial statements 2020

CVR: 37005665

Source: annual report 2020, Danish Business Authority

01/07/2019 – 30/06/2020

Sunrise Medical ApS (CVR 37005665) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 8,938,630 and a net result of DKK -3,273,267 compared with DKK -2,839,742 the year before. That is a decrease of 18.2% compared with the year before. Equity in the 2020 report amounted to DKK 3,015,064. The solvency ratio was 22.1%. The company had 19 employees in the financial year.

Gross Profit
DKK 8,938,630
Profit/Loss
DKK -3,273,267
Equity
DKK 3,015,064
Total Assets
DKK 13,635,308
Employees
19

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020-8.9M-3.3M3M19
2019-10.9M-2.8M3.5M20
2018-11.5M-2.4M6.3M21
2017-11.4M-3.3M-3.4M20
2016-6.4M-186K-136K-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Sunrise Medical ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

About Sunrise Medical ApS

Sunrise Medical ApS is a Danish company of the type Anpartsselskab based in Taastrup, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Adrian John Platt and James Louis Barratt. The board consists of Adrian John Platt (chair) and James Louis Barratt. The company is owned by Cidron Ollopa B.V.. The company has 22 employees (2026). In 2024, the company reported a gross profit of DKK 12,726,030 and a net result of DKK 1,921,194 compared with DKK 1,408,512 the year before. Equity in the 2024 report amounted to DKK 6,586,965.

Source: annual report 2024, Danish Business Authority